Drawing for 2 BIND MOLECULAR INTERACTIONS

USPTO serial 79330918

2 BIND MOLECULAR INTERACTIONS

Reviewed by CopyMark Law Group

Reg. 7141196Status 700Registered
Filing date
Status date
Registration date
Aug 22, 2023
Examiner
OJEYEMI,ASHLEY CHRISTINE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with 2 BIND MOLECULAR INTERACTIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elissa A. Tisdahl

Elissa A. Tisdahl Weisberg I.P. Law, P.A.1232 N. University DrivePlantation, FL 33322United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biological agents, compounds, preparations, reagents and substances for scientific, research, laboratory purposes, other than for medical or veterinary purposes; chemical, biochemical and biological preparations for use in biophysical and biotechnological, scientific, research, laboratory, industrial, and commercial process; diagnostic reagents, buffers, buffer solutions, buffer-screening stock solutions, bioliquids, ligands, therapeutic antibodies, monoclonal antibodies, antibody reagents, proteins, aptamers, antigens, and biochemicals for in vitro and in vivo applications for scientific, research, laboratory purposes, all the aforesaid except for medical and veterinary purposes; chemical, biochemical and biological agents, compounds, preparations, reagents and substances for the development, manufacture and research of pharmaceutical preparation, medicines, medicine products, medical diagnostics, diagnostic and analysis products, food, cosmetics, cleaning preparation and disinfectants in the fields of biology, biotechnology, biochemistry, chemistry, pharmacy and cosmetics, other than for medical or veterinary purposes; chemical, biochemical and biological preparations for the development, manufacture and research of biophysical and biotechnological pharmaceutical preparation, medicines, medical products, medical diagnostics, diagnostic and analysis products, food, cosmetics, cleaning preparations, and disinfectantsACTIVE—
042Scientific services, namely, conducting of biophysical interaction analyses by means of microscale thermophoresis technology for determining binding parameters of molecular interactions; scientific laboratory services, namely, plasmid cloning, protein expression in E. coli, protein purification and fluorescent protein marking; scientific and technological services, namely, scientific research, analysis, testing in the field of biophysical analytics; research and development services in the fields of pharmacy, biology, molecular biology, genetic science, biochemistry, biotechnology, chemistry, food industry and cosmetics; medical and pharmaceutical research and development; scientific, technological and industrial biochemical analysis and research; scientific laboratory services; scientific research laboratory services; analytical scientific laboratory services; conducting of scientific experiments and tests, namely, testing of pharmaceuticals, cosmetics, foodstuff, medical products, medical diagnostics, diagnostic, and analysis products; consultancy in the field of scientific, industrial and technological research and development in the pharmaceutical, medicinal, cosmetics, food stuff, and biotechnology fields; conducting of technical scientific feasibility studies; development of industrial processes, namely, development of testing specifications and procedures in the field of biophysical analytics; development of new products; development of new technology for others in the field of biophysical analytics; services for the development of methods of testing in the fields of pharmaceuticals and vaccines, cosmetics, food stuff, medical products, medical diagnostics, diagnostic and analysis products; research and development services and industrial, scientific and technological laboratory services in the field of protein and RNA-based medicine development, antibody development, protein analysis, aptamer development and the determination of molecular interactionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 1, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 25, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 30, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Dec 30, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 30, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 30, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 30, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 11, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 22, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 22, 2023FIMPFINAL DISPOSITION PROCESSED—
Nov 22, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 22, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 22, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 3, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 18, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 14, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 6, 2023GPNXNOTIFICATION PROCESSED BY IB—
Jun 6, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 6, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 17, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 17, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 17, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 4, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 23, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 22, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 22, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 22, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 6, 2023DOCKASSIGNED TO EXAMINER—
Mar 6, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Mar 6, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 6, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 21, 2023DOCKASSIGNED TO EXAMINER—
Dec 7, 2022ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Nov 22, 2022PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Nov 8, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 31, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 31, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 31, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 17, 2022DOCKASSIGNED TO EXAMINER—
Apr 11, 2022RFNTREFUSAL PROCESSED BY IB—
Mar 21, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 21, 2022RFRRREFUSAL PROCESSED BY MPU—
Feb 18, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 17, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2022DOCKASSIGNED TO EXAMINER—
Jan 18, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 14, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 13, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance